Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily J Koller

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
NPJ Parkinson'S Disease|March 20, 2021
Il-10 signaling reduces survival in mouse models of synucleinopathySamuel G Cockey, Karen N McFarland, Emily J Koller, et al.
The Journal of Experimental Medicine|August 31, 2018
TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's diseaseParamita Chakrabarty, Andrew Li, Thomas B Ladd, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
NPJ Parkinson'S Disease|March 20, 2021
Il-10 signaling reduces survival in mouse models of synucleinopathySamuel G Cockey, Karen N McFarland, Emily J Koller, et al.
The Journal of Experimental Medicine|August 31, 2018
TLR5 decoy receptor as a novel anti-amyloid therapeutic for Alzheimer's diseaseParamita Chakrabarty, Andrew Li, Thomas B Ladd, et al.
Pageof 2